
Risk assessment of thin melanomas
Prof Dr Bart Neyns and Dr Jolien Kessels presented findings from a retrospective study on early-stage melanoma at EADO 2025. The study focused on improving prognosis prediction for patients with
MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world. In collaboration with Belgian and international experts, we bring the newest data in several different formats to Belgian physicians.
Latest publications
Prof Dr Bart Neyns and Dr Jolien Kessels presented findings from a retrospective study on early-stage melanoma at EADO 2025. The study focused on improving prognosis prediction for patients with
Prof Anna Czarnecka, a medical oncologist from the National Research Cancer Institute in Warsaw, presented two important studies from the Polish Melanoma Group at EADO 2025 in Athens.
Prof Dr Lieve Brochez from the University Hospital Gent, Belgium, presented research from the Skin Cancer Research Institute Gent at the EADO 2025 meeting in Athens. The focus was on
At the 2025 EADO Congress, Prof Dr Georgina Long and Prof Dr Bart Neyns share perspectives on the evolving role of neoadjuvant immunotherapy in resectable stage III melanoma. While not
Prof Dr Mireille Fontsa Langouo provides some key insights into treating acral
lentiginous melanoma (ALM). She also emphasises the emerging role of
biomarkers in predicting patient response and